Friday’s Top Biotech and Medical Stocks

Photo of Douglas A. McIntyre
By Douglas A. McIntyre Published

From BioHealth Investor

Biotechnology

REXAHN PHARMACEUTICL [RXHN.OB] +18.18%
LPATH INC [LPTN.OB] +14.29%
NEURALSTEM INC [NRLS.OB] +8.60%
CELL GENESYS INC [CEGE] +7.85%
ORTHOLOGIC CP [OLGC] +7.64%

Diagnostic Substances

SCOLR PHARMA INC [DDD] +5.71%
AVIGEN INC [AVGN] +4.58%
THRESHOLD PHARMACEUT [THLD] +4.40%
SONUS PHARM INC [SNUS] +3.68%
AVANT IMMUNOTHERAP [AVAN] +3.60%

Drug Delivery

INSITE VISION INC [ISV] +6.62%
QUIGLEY CORP THE [QGLY] +3.27%
PETMED EXPRESS INC [PETS] +1.91%
NOVADEL PHARMA INC [NVD] +1.74%
DELCATH SYSTEMS INC [DCTH] +1.05%

Drug Manufacturers

EXEGENICS INC [EXEG.OB] +10.29%
GEOPHARMA INC [GORX] +4.71%
SIGA TECH INC [SIGA] +3.50%
NEUROCHEM INC [NRMX] +3.18%
AP PHARMA INC [APPA] +3.10%

Medical Appliances & Equipment

MEDIS TECH LTD [MDTL] +8.05%
MICROTEK MED HLDGS [MTMD] +5.09%
SPAN AMERICA MED S [SPAN] +5.08%
ESCALON MED CP [ESMC] +4.68%
ALLIED HEALTHCARE [AHPI] +4.12%

Medical Instruments & Supplies

MILESTONE SCIENTIFIC [MLSS.OB] +10.87%
TUTOGEN MEDICAL INC [TTG] +8.27%
EP MEDSYSTEMS INC [EPMD] +8.22%
PRO-DEX INC NEW [PDEX] +7.69%
BIOFORCE NANOSCIENCE [BFNH.OB] +6.59%

Medical Laboratories & Research

GENOMIC HEALTH, INC. [GHDX] +0.26%

http://www.biohealthinvestor.com/

Contact [email protected] for any questions or corrections.

Photo of Douglas A. McIntyre
About the Author Douglas A. McIntyre →

Douglas A. McIntyre is the co-founder, chief executive officer and editor in chief of 24/7 Wall St. and 24/7 Tempo. He has held these jobs since 2006.

McIntyre has written thousands of articles for 24/7 Wall St. He is an expert on corporate finance, the automotive industry, media companies and international finance. He has edited articles on national demographics, sports, personal income and travel.

His work has been quoted or mentioned in The New York Times, The Wall Street Journal, Los Angeles Times, The Washington Post, NBC News, Time, The New Yorker, HuffPost USA Today, Business Insider, Yahoo, AOL, MarketWatch, The Atlantic, Bloomberg, New York Post, Chicago Tribune, Forbes, The Guardian and many other major publications. McIntyre has been a guest on CNBC, the BBC and television and radio stations across the country.

A magna cum laude graduate of Harvard College, McIntyre also was president of The Harvard Advocate. Founded in 1866, the Advocate is the oldest college publication in the United States.

TheStreet.com, Comps.com and Edgar Online are some of the public companies for which McIntyre served on the board of directors. He was a Vicinity Corporation board member when the company was sold to Microsoft in 2002. He served on the audit committees of some of these companies.

McIntyre has been the CEO of FutureSource, a provider of trading terminals and news to commodities and futures traders. He was president of Switchboard, the online phone directory company. He served as chairman and CEO of On2 Technologies, the video compression company that provided video compression software for Adobe’s Flash. Google bought On2 in 2009.

Continue Reading

Top Gaining Stocks

META Vol: 15,543,976
KMX Vol: 242,135
WY Vol: 1,312,728
AOS Vol: 136,719
BLDR Vol: 151,994

Top Losing Stocks

MRNA Vol: 2,416,637
CTRA Vol: 73,319,495
DDOG Vol: 1,012,006
INTC Vol: 19,923,505
CRWD Vol: 1,016,854